AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
IRON SUCROSE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| AKUROSE SOLUTION; INJECTION | 2021/10.1.1/6124 | UNOSOURCE PHARMA LTD | active | 19 Apr 2031 |
| AMPOFER SOLUTION; INJECTION | 2025/10.1/6875 | COSPHARM INVESTMENTS PVT LTD | active | 25 Feb 2030 |
| HAEM UP INJECTION SOLUTION | 2015/10.1.1/5133 | CADILA PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
| ENCIFER INJECTABLE; INJECTION | 2011/10.1.1/4686 | EMCURE PHARMACEUTICALS LTD | active | 31 Dec 2027 |
| INNOFER LIQUID; ORAL | 2017/10.1.1/5463 | INNOVATA PHARMACEUTICALS LTD | active | 31 Dec 2027 |
IRON SUCROSE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing IRON SUCROSE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track IRON SUCROSE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.